WO2002085409A3 - Procedes et compositions permettant d'induire une reponse immunitaire - Google Patents

Procedes et compositions permettant d'induire une reponse immunitaire Download PDF

Info

Publication number
WO2002085409A3
WO2002085409A3 PCT/US2001/045717 US0145717W WO02085409A3 WO 2002085409 A3 WO2002085409 A3 WO 2002085409A3 US 0145717 W US0145717 W US 0145717W WO 02085409 A3 WO02085409 A3 WO 02085409A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
antigen
inducing
immune response
Prior art date
Application number
PCT/US2001/045717
Other languages
English (en)
Other versions
WO2002085409A2 (fr
Inventor
Thomas J Schall
Dale Talbot
Robert Berkovitz
Wei Zheng
Maureen Howard
Brett Premack
Original Assignee
Chemocentryx
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemocentryx filed Critical Chemocentryx
Priority to AU2002228729A priority Critical patent/AU2002228729A1/en
Publication of WO2002085409A2 publication Critical patent/WO2002085409A2/fr
Publication of WO2002085409A3 publication Critical patent/WO2002085409A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Cette demande concerne de façon générale l'amélioration des réponses immunitaires. De telles réponses immunitaires peuvent être sollicitées par l'administration de vaccins. L'invention concerne des compositions et des procédés permettant d'induire ou d'améliorer une réponse immunitaire causée par un antigène. Ces compositions et procédés sont utiles notamment pour la formulation de vaccins à des fins de vaccination thérapeutique et prophylactique (immunisation) et la production d'anticorps utiles (notamment, d'anticorps monoclonaux à des fins thérapeutiques ou diagnostiques).
PCT/US2001/045717 2001-04-12 2001-10-30 Procedes et compositions permettant d'induire une reponse immunitaire WO2002085409A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002228729A AU2002228729A1 (en) 2001-04-12 2001-10-30 Methods and compositions for inducing an immune response to an antigen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83481401A 2001-04-12 2001-04-12
US09/834,814 2001-04-12

Publications (2)

Publication Number Publication Date
WO2002085409A2 WO2002085409A2 (fr) 2002-10-31
WO2002085409A3 true WO2002085409A3 (fr) 2002-12-27

Family

ID=25267873

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/045717 WO2002085409A2 (fr) 2001-04-12 2001-10-30 Procedes et compositions permettant d'induire une reponse immunitaire

Country Status (2)

Country Link
AU (1) AU2002228729A1 (fr)
WO (1) WO2002085409A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003035106A1 (fr) * 2001-10-24 2003-05-01 Chemocentryx Procedes et compositions servant a induire une reponse immune

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004282A1 (fr) * 1996-07-25 1998-02-05 The Regents Of The University Of California Immunotherapie du cancer au moyen de cellules tumorales autologues combinees a des cellules allogeniques secretant une cytokine
WO1999029728A1 (fr) * 1997-12-11 1999-06-17 University Of Maryland Biotechnology Institute Procede et composition pour ameliorer l'efficacite d'un vaccin
EP0974357A1 (fr) * 1998-07-16 2000-01-26 Schering-Plough Chemokines comme adjuvants de la réponse immunitaire
WO2001080887A2 (fr) * 2000-04-21 2001-11-01 Chemocentryx, Inc. Techniques et compositions permettant d'induire une reponse immunitaire

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998004282A1 (fr) * 1996-07-25 1998-02-05 The Regents Of The University Of California Immunotherapie du cancer au moyen de cellules tumorales autologues combinees a des cellules allogeniques secretant une cytokine
WO1999029728A1 (fr) * 1997-12-11 1999-06-17 University Of Maryland Biotechnology Institute Procede et composition pour ameliorer l'efficacite d'un vaccin
EP0974357A1 (fr) * 1998-07-16 2000-01-26 Schering-Plough Chemokines comme adjuvants de la réponse immunitaire
WO2001080887A2 (fr) * 2000-04-21 2001-11-01 Chemocentryx, Inc. Techniques et compositions permettant d'induire une reponse immunitaire

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DE GIOVANNI CARLA ET AL: "The prospects for cancer gene therapy.", INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, vol. 22, no. 12, December 2000 (2000-12-01), pages 1025 - 1032, XP002218907, ISSN: 0192-0561 *
GREAVES DAVID R ET AL: "Chemokines and myeloid cell recruitment.", MICROBES AND INFECTION, vol. 2, no. 3, March 2000 (2000-03-01), pages 331 - 336, XP002218908, ISSN: 1286-4579 *

Also Published As

Publication number Publication date
AU2002228729A1 (en) 2002-11-05
WO2002085409A2 (fr) 2002-10-31

Similar Documents

Publication Publication Date Title
WO2003011223A3 (fr) Composes immunomodulants et methodes d'utilisation
EP1568373A3 (fr) Induction de reponses immunes cellulaires a HER2/neu a l'aide de compositions renfermant des peptides et des acides nucleiques
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
WO2006036550A3 (fr) Vaccins a base de llo et de listeria
BRPI0312472B8 (pt) composição compreendendo dois complexos iscom diferentes
WO2004075829A3 (fr) Vaccin contre la grippe contenant un adjuvant
EE200200507A (et) Muundatud vaktsiiniaviirus Ankara (MVA), sellega nakatatud peremeesrakk ning seda sisaldav farmatseutiline kompositsioon, MVA valmistamine ja raviotstarbeline kasutamine
NO20071609L (no) Immunogen sammensetning for anvendelse ved vaksinering mot stafylokokker
EP1659178A3 (fr) Dérivés antigènes associés aux tumeurs de la famille mage, et séquences d'acides nucléiques codant ces dérivés, utilisés pour la préparation de protéines de fusion et de compositions destinées à la vaccination
EP1246644A4 (fr) Reponse immunitaire cellulaire au papillomavirus humain induite par utilisation de compositions peptidiques et d'acide nucleique
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
WO2004026265A3 (fr) Procedes d'identification de vaccin et compositions de vaccination comprenant des sequences d'acides nucleiques et/ou de polypeptides de la famille du virus de l'herpes
MXPA01007760A (es) Compuesto adyuvante inmunologico.
BR0211296A (pt) Peptìdeo imunogênico derivado da proteìna g do vrs do sub-grupo a ou b, sequência de ácido nucleico, composição farmacêutica, anticorpos policlonais ou monoclonais, kit de diagnóstico, utilização de um peptìdeo imunogênico, e, conjugado
WO2005084306A3 (fr) Compositions immunogenes pour chlamydia pneunomiae
WO2004073319A8 (fr) Methodes et composes pour le prelevement d'anticorps et le criblage de repertoires d'anticorps
CA2272338A1 (fr) Immunisation de nourrissons
WO2006105993A3 (fr) Procede permettant de proteger des sites fonctionnels ou des epitopes sur des proteines
WO2002087494A3 (fr) Nouveau vaccin
WO2005007673A3 (fr) Peptides immunogenes
MY125000A (en) Novel compositions
WO2004037175A3 (fr) Compositions et methodes pour traiter une maladie a mediation par le papillomavirus humain (hpv)
WO2005000884A8 (fr) Conjugues d'acide poly-gamma-glutamique pour solliciter des reponses immunitaires dirigees contre des bacilles
AU2001284354A1 (en) Immunological adjuvant compounds, compositions, and methods of use thereof
WO2002034287A3 (fr) Nouvelles formulations de vaccin therapeutique

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP